Tower Research Capital (TRC)’s Aethlon Medical AEMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $848 | Buy |
707
+702
| +14,040% | +$842 | ﹤0.01% | 4928 |
|
2025
Q1 | $14 | Sell |
5
-473
| -99% | -$1.32K | ﹤0.01% | 5106 |
|
2024
Q4 | $3.29K | Sell |
478
-510
| -52% | -$3.51K | ﹤0.01% | 4676 |
|
2024
Q3 | $3.68K | Buy |
988
+126
| +15% | +$470 | ﹤0.01% | 4798 |
|
2024
Q2 | $3.44K | Buy |
862
+720
| +507% | +$2.87K | ﹤0.01% | 4889 |
|
2024
Q1 | $1.91K | Buy |
142
+7
| +5% | +$94 | ﹤0.01% | 5156 |
|
2023
Q4 | $2.37K | Buy |
135
+28
| +26% | +$491 | ﹤0.01% | 5229 |
|
2023
Q3 | $1.93K | Hold |
107
| – | – | ﹤0.01% | 5239 |
|
2023
Q2 | $3.07K | Sell |
107
-1
| -0.9% | -$29 | ﹤0.01% | 5093 |
|
2023
Q1 | $3K | Hold |
108
| – | – | ﹤0.01% | 5164 |
|
2022
Q4 | $2K | Sell |
108
-7
| -6% | -$130 | ﹤0.01% | 5317 |
|
2022
Q3 | $5K | Buy |
115
+63
| +121% | +$2.74K | ﹤0.01% | 5117 |
|
2022
Q2 | $4K | Sell |
52
-12
| -19% | -$923 | ﹤0.01% | 5160 |
|
2022
Q1 | $8K | Buy |
64
+53
| +482% | +$6.63K | ﹤0.01% | 4548 |
|
2021
Q4 | $2K | Buy |
11
+3
| +38% | +$545 | ﹤0.01% | 5591 |
|
2021
Q3 | $3K | Sell |
8
-175
| -96% | -$65.6K | ﹤0.01% | 5071 |
|
2021
Q2 | $72K | Buy |
183
+180
| +6,000% | +$70.8K | ﹤0.01% | 2696 |
|
2021
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 5356 |
|
2016
Q4 | – | Sell |
-1
| Closed | -$3K | – | 3776 |
|
2016
Q3 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 2805 |
|
2016
Q2 | – | Sell |
-1
| Closed | -$5K | – | 4376 |
|
2016
Q1 | $5K | Buy |
+1
| New | +$5K | ﹤0.01% | 2646 |
|
2015
Q4 | – | Hold |
0
| – | -$1K | – | 3674 |
|
2015
Q3 | – | Hold |
0
| – | – | – | 3555 |
|